Survivor Stories
Real cancer patients share how they accessed advanced treatment through CancerFax — honest journeys, real outcomes, real hope.
Stories
All Survivor Stories
Zainab
Diagnosed with leukemia days before her wedding, Zainab from Pakistan travelled to China for advanced cell and gene therapy and returned home to a new beginning.
Shakib
After CAR-T did not control his B-cell leukemia, Shakib from Jordan reached complete MRD-negative remission through a stem cell transplant in China.
Rodney
Rodney, 68, with relapsed high-risk DLBCL, accessed dual CD19/CD20 CAR-T therapy in China. Early Day 10 monitoring showed strong CAR-T expansion with no severe toxicity.
Bjørn
From Norway to China for BCMA CAR-T cell therapy: how Bjørn navigated a month of COVID isolation and reached complete remission from multiple myeloma.
V.I.
After relapsed B-ALL returned despite a stem cell transplant and several therapies, V.I. reached MRD-negative status following CD19 CAR-T in China.
Shefali
After a rare nerve-sheath sarcoma was removed from the back of her head with an involved margin, Shefali travelled from Bangladesh to BLK Super Speciality Hospital in New Delhi for tumour-board-led radiation and targeted therapy.
Mesfin
After his colon cancer returned and local surgical options were limited, Mesfin travelled from Ethiopia to BLK Super Speciality Hospital in New Delhi for specialist surgical care.
Hasan
After his gastric DLBCL returned following an initial complete response, Hasan travelled from Iran to Beijing to access CD19 CAR-T cell therapy.
Chen Yen
Diagnosed with severe beta-thalassemia at eight months and transfused for over twenty years, Chen Yen became transfusion independent after gene-edited stem cell therapy in China.
Nasser
A 30-year-old man from Egypt with lymphoma whose case was reviewed by a multidisciplinary team at Lu Daopei Hospital in China, where a CAR-T cell therapy clinical trial pathway was identified after detailed evaluation.
Saifullah
A 14-year-old boy from Pakistan with MRD-positive Pre-B ALL travelled to Beijing for CD19 CAR-T cell therapy after chemotherapy left residual disease behind.
Anton
After relapsed B-ALL stopped responding to chemotherapy in Russia, Anton accessed CD19 CAR-T cell therapy at Lu Daopei Hospital in Beijing and entered complete remission.
Abdurrahman
A 68-year-old man from Turkey with relapsed and refractory multiple myeloma travels to Lu Daopei Hospital in China to access BCMA CAR-T cell therapy. Treatment is ongoing.
Abigail
Diagnosed with a grade 3 invasive ductal carcinoma in Zimbabwe, Abigail travelled to India for surgery, radiation and hormone therapy. Five years on, she is well with no evidence of disease.
Mukhtar Mohammed
A 19-year-old from Ethiopia with severe aplastic anemia received a matched-donor bone marrow transplant in India. His younger brother was the donor, and today he works as a pharmacist.
Arjun Kandpal
""There were days I could not recognize my reflection. Days when my family cried quietly so I wouldn't hear them. But treatment gave me back something I thought I had lost forever: time. It is time once more to laugh, to enjoy my mother's cooking, and to bask in the sunlight. No remedy can quantify what that signifies. — Arjun, 28 | DMG Patient"
Alexander
"“I came with fear and uncertainty but found hope, expert care, and genuine compassion here. The team supported me medically and emotionally, giving me confidence to move forward.”"
Mohammed H
"“Before, the pain was everywhere, and I thought this was the end. After the CAR-T treatment in China, I feel like a new person. The latest scan shows the cancer is almost gone. I am so grateful.”"